Fevertree share price: where next ahead of its H1 results?
The maker of premium carbonated mixers is set to unveil its half-year (H1) results on 8 September, with the company delivering a resilient performance, reflected in its share price.
- Fevertree delivers resilient performance amid Covid-19, reflected in its share price
- Analysts at Barclays believe stock could hit £25 per share
- Fevertree confident it can deliver on its full-year 2020 outlook
Fevertree Drinks PLC is set to unveil its half-year (H1) results on 8 September, with the company delivering a relatively resilient performance despite the economic fallout from Covid-19, which has been reflected in its share price.
As it stands, the maker of premium carbonated mixers is trading 1% higher year-to-date, beating the broader market with the FTSE 100 still down 22% over the same period.
Investors are eager for an update on the company’s performance, with Fevertree’s stock capable of pushing to higher highs this year if it is able to deliver on its full-year 2020 outlook.
Analysts at Barclays believe stock could hit £25 per share
Analysts at Barclays are confident that the company will make good on its ambitions this year, with the bank reiterating its ‘overweight’ rating for the stock and issuing a target price of £25.
Based on Fevertree closing at £21.20 on Monday, analysts at Barclays believe the stock has a potential upside of 18%.
Fevertree confident it can deliver on FY20 outlook
The drinks maker had a solid start to the year, with trading in the first two months falling in-line with its expectations. However, from March onwards, trading across its regions was dominated by the economic fallout from Covid-19, leading to widespread closures of its on-trade business, though its off-trade channels continued to deliver a strong performance.
In fact, Fevertree’s off-trade revenues (sales occurring in supermarkets and convenience stores etc…) for the last 12 weeks to 14 June increased 34% year-on-year s the popularity of long mixed drinks as an everyday affordable treat continues to resonate with consumers.
‘As previously highlighted, the changes in channel and territory mix resulting from Covid-19 are expected to lead to gross margin headwinds during this financial year,’ Fevertree said.
‘However, we remain committed to our planned investments, particularly in marketing, and therefore intend to maintain our budgeted circa £60 million of operational costs for the full year, enabled by the group's strong balance sheet and conviction in our ability to deliver long-term sustainable growth.’
Acquisition of GDP crucial to optimise performance in Germany
Earlier this year, Fevertree announced its acquisition of Global Drinks Partnership (GDP), the group’s sales agent in Germany.
‘The completion of the GDP acquisition is an important step as we execute our growth plans in Germany, providing us with an ideal platform to take advantage of the opportunity within the German market and accelerate our growth,’ Fevertree CEO Tim Warrillow said.
‘I have worked closely with Morgan Zuill and his team at GDP since we first entered the German market and have been impressed with their approach and expertise in growing the Fever-Tree brand, so I am delighted that they are joining the Fever-Tree team,’ he added.
How to trade stocks with IG
- Create an IG trading account or log in to your existing account
- Enter ‘Fevertree Drinks PLC’ in the search bar and select it
- Choose your position size
- Click on ‘buy’ or ‘sell’ in the deal ticket
- Confirm the trade
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
Please see important Research Disclaimer.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.